https://www.selleckchem.com/products/loxo-195.html
7% vs 2.9%; p0.001). Median (IQR) % improvement in GERD-HRQL was significantly higher in the EFTP group at 6 (81.4 (60.9-100. versus 8.0 (2.2-21.6); p0.001) and 12 (92.3 (84.4-100. versus 9.1 (4.8-36.; p0.001) months. In the EFTP group, 62.8% patients were off-PPI at 12 months compared with 11.4% in the sham group (p0.001). pH-metry parameters partially improved at 3 months, (n=70; total reflux episodes in EFTP arm and non-acid reflux episodes for EFTP vs sham) but not at 12 months (n=27); endoscopic oesophagitis